Skip to main content

Market Overview

UPDATE: Citi Lowering Price Target on Catalyst Health Solutions

Share:

Citi Investment Research is out with a research report on Catalyst Health Solutions, Inc. (NASDAQ: CHSI) and it is lowering its price target to $63 from $74, and it has a Buy rating on shares.

In a note to clients, Citi Investment Research writes, "CHSI shares have sold off about 15% since the company lowered 2012 EPS guidance and announced the increased spending. We believe the decline may have created a unique entry point for patient shareholders, recognizing that the fruits of Catalysts' investments in both WHI and the Invest Now initiative are not likely to be known until 2H-12. Our target price of $63 is based on 23x 2012E EPS of $2.74, reflecting our 2010-2015 EPS CAGR of 22-24%. While CHSI shares could tread water for the remainder of this year, new business wins and the delivery of acquisition synergies could drive share price outperformance in 2012."

Shares of CHSI lost $1.83 yesterday to close at $47.36.

 

Related Articles (CHSI)

View Comments and Join the Discussion!

Posted-In: Citi Investment ResearchAnalyst Color Price Target Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com